Description: Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Home Page: filament.health
4475 Wayburne Drive
Burnaby,
BC
V5G 4X4
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Benjamin Lightburn | Co-Founder, CEO & Chairman |
| Ms. Lisa Ranken | Chief Operating Officer |
| Mr. Ryan Moss | Chief Science Officer |
| Mr. Jonathan Conlin | Corporate Secretary & Director |
| Mr. Steven Nguyen CPA | Interim Chief Financial Officer |
| Ms. Anna Cordon | Vice President of Marketing & Communications |
| Mr. Jeff Fellows | Head of Regulatory |
| Andry Tjahyana | VP of Business Development |
| Sara Burke B.A., M.B.A. | Head of Global Partnerships |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.9467 |
| Price-to-Sales TTM: | 5.9922 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 13 |